Chaparro, M, Baston-Rey, I, Salgado, EF, Garcia, JG, Ramos, L, Palomares, MTDL, Arguelles-Arias, F, Flores, EI, Cabello, M, Iturria, SR, Ortiz, AN, Charro, M, Ginard, D, Sadornil, CD, Ochoa, OM, Busquets, D, Iyo, E, Casbas, AG, de la Piscina, PR, Bosca-Watts, MM, Arroyo, M, Garcia, MJ, Hinojosa, E, Gordillo, J, Montiel, PM, Jimenez, BV, Ivorra, CQ, Moron, JMV, Huguet, JM, Gonzalez-Lama, Y, Santos, AIM, Amo, VM, Arranz, MDM, Bermejo, F, Cadilla, JM, de Celix, CR, Salazar, PF, San Roman, AL, Jimenez, N, Garcia-Lopez, S, Figuerola, A, Jimenez, I, Cerezo, FJM, Taxonera, C, Varela, P, de Francisco, R, Monfort, D, Arriero, GM, Hernandez-Camba, A, Alonso, FJG, Van Domselaar, M, Pajares-Villarroya, R, Nunez, A, Moranta, FR, Marin-Jimenez, I, Alonso, VR, Rodriguez, MDM, Camo-Monterde, P, Tercero, IG, Navarro-Llavat, M, Garcia, LA, Cruz, DH, Kloss, S, Passey, A, Novella, C, Vispo, E, Barreiro-de Acosta, M, Gisbert, JP. Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn's Disease Patients on Ustekinumab. Journal of Clinical Medicine. 2022; 11(15)DOI:10.3390/jcm11154518. PMID:35956133. IF:3.900(Q2/4D).

Riestra, S, Taxonera, C, Zabana, Y, Carpio, D, Chaparro, M, Barrio, J, Rivero, M, Lopez-Sanroman, A, Esteve, M, de Francisco, R, Bastida, G, Garcia-Lopez, S, Manosa, M, Martin-Arranz, MD, Perez-Calle, JL, Guardiola, J, Munoz, F, Arranz, L, Cabriada, JL, Garcia-Sepulcre, MF, Navarro, M, Montoro-Huguet, MA, Ricart, E, Bermejo, F, Calvet, X, Piqueras, M, Garcia-Planella, E, Marquez, L, Minguez, M, Van Domselar, M, Bujanda, L, Aldeguer, X, Sicilia, B, Iglesias, E, Alcain, G, Perez-Martinez, I, Rolle, V, Castano-Garcia, A, Gisbert, JP, Domenech, E. Performance of Screening Strategies for Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease: Results from the ENEIDA Registry of GETECCU. Journal of Clinical Medicine. 2022; 11(13)DOI:10.3390/jcm11133915. PMID:35807201. IF:3.900(Q2/4D).

Alvarado-Tapias, E, Maya-Miles, D, Albillos, A, Aller, R, Ampuero, J, Andrade, RJ, Arechederra, M, Aspichueta, P, Banales, JM, Blas-Garcia, A, Caparros, E, Delgado, TC, Carrillo-Vico, A, Claria, J, Cubero, FJ, Diaz-Ruiz, A, Fernandez-Barrena, MG, Fernandez-Iglesias, A, Fernandez-Veledo, S, Frances, R, Gallego-Duran, R, Gracia-Sancho, J, Irimia, M, Lens, S, Martinez-Chantar, ML, Minguez, B, Munoz-Hernandez, R, Nogueiras, R, Ramos-Molina, B, Riveiro-Barciela, M, Rodriguez-Peralvarez, ML, Romero-Gomez, M, Sabio, G, Sancho-Bru, P, Ventura-Cots, M, Vidal, S, Gahete, MD. Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH). Gastroenterologia y Hepatologia. 2024; 47(10)DOI:10.1016/j.gastrohep.2024.502207. PMID:38723772. IF:1.900(Q3/7D).

González-Muñoza, C, Gely, C, Gordillo, J, Calafat, M, Bertoletti, F, Cañete, F, Mañosa, M, López-Faba, A, Torres, P, Domènech, E, Garcia-Planella, E. Perception of the impact of intravenous biological treatment on the work and professional environment in patients with inflammatory bowel disease. Gastroenterologia y Hepatologia. 2024; 47(10)DOI:10.1016/j.gastrohep.2024.502193. PMID:38723767. IF:1.900(Q3/7D).

Casanova, MJ, Caballol, B, García, MJ, Mesonero, F, de Célix, CR, Suárez-Alvarez, P, Ferreiro-Iglesias, R, Martín-Rodríguez, MDM, de Francisco, R, Varela-Trastoy, P, Bastida, G, Carrillo-Palau, M, Núñez-Ortiz, A, Ramírez-de la Piscina, P, Ceballos, D, Hervías-Cruz, D, Muñoz-Pérez, R, Velayos, B, Bermejo, F, Busquets, D, Cabacino, M, Camo-Monterde, P, Marín-Jiménez, I, Muñoz, C, de la Peña-Negro, LC, Sierra-Moros, E, Barrio, J, Brunet-Mas, E, Bujanda, L, Cañete, F, Gomollón, F, Manceñido-Marcos, N, Rodríguez-Lago, I, Rodríguez-Grau, MC, Sicilia, B, Torra-Alsina, S, Arranz-Hernández, L, Carpio, D, García-Sepulcre, MF, González-Muñoza, C, Huguet, JM, Márquez-Mosquera, L, López-Serrano, MP, Ponferrada-Díaz, A, Chaparro, M, Gisbert, JP. Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCU. DIGESTIVE AND LIVER DISEASE. 2024; 56(11)DOI:10.1016/j.dld.2024.05.009. PMID:38839456. IF:3.800(Q2/3D).

Brujats, A, Villanueva, C. Examining the therapeutic landscape of beta-blockers in portal hypertension. Clinical and Molecular Hepatology. 2024; 30(4)DOI:10.3350/cmh.2024.0144. PMID:38447532. IF:16.900(Q1/1D).